Total Q2 revenue of $12.0 million and net income of $4.6 million
Product sales and royalty revenue of $6.5 million up 175% from Q2 2022 and 22% from Q1 2023
$21.6 million of cash on hand
Launched Betaine Anhydrous
Management to hold conference call today at 4:30pm ET
Eton will host its second quarter 2023 conference call as follows:
Date: | Thursday, August 10, 2023 | |
|
|
|
In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: investorrelations@etonpharma.com.
The live webcast can be accessed on the Investors section of Eton’s website at https://ir.etonpharma.com/. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.
* Conference call participants should register to obtain their dial-in and passcode details. Please be sure to register using a valid email address.
https://finance.yahoo.com/news/eton-pharmaceuticals-reports-second-quarter-200100308.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.